These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent. Ogawa K, Mukai T, Inoue Y, Ono M, Saji H. J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748 [Abstract] [Full Text] [Related]
9. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent. Qiu L, Lin J, Nan B, Lv G, Cheng W. Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712 [Abstract] [Full Text] [Related]
10. Synthesis and pharmacological evaluation of 99mTc-labeled imidazolyl-containing diphosphonic acid as a novel bone imaging agent. Qiu L, Cheng W, Lin J, Zhang S, Luo S. J Labelled Comp Radiopharm; 2013 Sep; 56(11):573-80. PubMed ID: 24285189 [Abstract] [Full Text] [Related]
11. 99mTc-zolmitriptan: radiolabeling, molecular modeling, biodistribution and gamma scintigraphy as a hopeful radiopharmaceutical for lung nuclear imaging. Rashed HM, Marzook FA, Farag H. Radiol Med; 2016 Dec; 121(12):935-943. PubMed ID: 27586132 [Abstract] [Full Text] [Related]
19. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication. Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M. J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854 [Abstract] [Full Text] [Related]